Recall Register

Drug recall: PremierZen Extreme 3000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio…

Class II FDA enforcement event 87711. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Hyobin LLC started this drug recall on 6 Apr 2021. The firm address in the FDA record is in Ridgewood, NJ. FDA put the recall in Class II. FDA event 87711 has 3 product records. The first FDA enforcement report date is 26 May 2021. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

USA Nationwide

Recalling firm

Hyobin LLC, Ridgewood, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

3 product records in the event.

FDA event 87711: product records
Recall numberProductQuantityClassStatusReport date
D-0381-2021PremierZen Extreme 3000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ500 cardsClass IIOngoing26 May 2021
D-0382-2021PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ500 cardsClass IIOngoing26 May 2021
D-0383-2021Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ300 cardsClass IIOngoing26 May 2021

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2021
299
Share of these events in Class II
60%
Product records in this event
3
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 87711. https://recallregister.com/fda/ii/87711/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: USA Nationwide
What quantity of product is in FDA event 87711?
The event has 3 product records. The first record gives this quantity: 500 cards
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2021 have the same class?
60% of the 299 drug events that started in 2021 are in Class II.